Background: Staphylococcus aureus causes various infections, including skin and soft tissue infections (SSTIs). In this study, methicillin-susceptible S. aureus (MSSA) from SSTIs among patients in three tertiary-care hospitals in Greece were studied in terms of antimicrobial resistance, clonal distribution, toxin and adhesin genes carriage.

Results: During a five-year period (2014-2018), 6145 S. aureus were recovered from 13,244 patients with SSTIs and tested for antimicrobial susceptibility. MSSA were 4806 (78.21 %) including 1484 isolates with mupirocin minimum inhibitory concentration (MIC) > 64 mg/L (30.88 %). Two hundred and sixty representative mupirocin-resistant MSSA were analyzed for genes encoding Panton-Valentine leukocidin (PVL, lukS/lukF-PV), exfoliative toxins (eta, etb), adhesin FnbA (fnbA) and resistance genes mupA (high-level resistance to mupirocin), fusB (fusidic acid), aminoglycosides' modifying enzymes, ermA, ermC and msrA (macrolides/lincosamides) by PCRs. Strains were classified into clones by PFGE and MLST. All mupirocin-resistant MSSA were penicillin-resistant; 92.7 % expressed resistance to fusidic acid and 88.9 % to tobramycin. All 260 molecularly analyzed isolates were mupA-positive; all fusidic acid-resistant (241/260) carried fusB whereas, the tobramycin-resistant ones (230), ant(4')-Ia. The majority carried eta (93.85 %), etb (98.08 %) and fnbA (88.85 %). PFGE typing revealed a mostly unvarying population; 260 MSSA were grouped into three types. One major eta/etb-positive clone comprising of 258/260 strains (99.2 %), PFGE type 1, was classified as ST121, including nine strains co-carrying PVL. Another PVL-positive strain was identified as ST1, and one toxins-negative as ST21.

Conclusions: A mupirocin-resistant MSSA clone, ST121, carrying resistance, exfoliative toxins and adhesin genes, was spread and predominated in SSTIs from patients in Greece during the five-year studied period.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254358PMC
http://dx.doi.org/10.1186/s12866-021-02272-5DOI Listing

Publication Analysis

Top Keywords

mupirocin-resistant mssa
12
staphylococcus aureus
8
skin soft
8
soft tissue
8
tissue infections
8
sstis patients
8
adhesin genes
8
exfoliative toxins
8
fusidic acid
8
mssa
6

Similar Publications

The increasing emergence of as the primary causative agent of otitis externa has been noted; however, detailed information regarding the molecular characteristics of these strains in Iran remains scarce. The current study aims to investigate both genotypic and phenotypic attributes of strains implicated in ear infections. In the present work, we analyzed 60  strains isolated from cases of otitis externa over a period of 45 months.

View Article and Find Full Text PDF

Emergence and spread of a mupirocin-resistant variant of the European epidemic fusidic acid-resistant impetigo clone of , Belgium, 2013 to 2023.

Euro Surveill

May 2024

National reference centre for Staphylococcus aureus and other species, Department of microbiology, Laboratoire Hospitalier Universitaire de Bruxelles - Universitair Laboratorium Brussel (LHUB-ULB), Université libre de Bruxelles, Brussels, Belgium.

Article Synopsis
  • Resistance to mupirocin and fusidic acid in community-acquired MSSA skin infections in Belgium is on the rise, emphasizing a significant public health concern.
  • Data collected from 2013 to 2023 showed mupirocin resistance increased from 0.5-1.5% to 1.7-5.6%, with a notable 91.4% of resistant strains also resistant to fusidic acid.
  • A specific mupirocin-resistant strain (sequence type 121) has become prevalent among children, carrying resistance genes and virulence factors, indicating a worrying trend for the effectiveness of current treatments for impetigo.
View Article and Find Full Text PDF

Introduction: Nasal carriage of species plays an important role in the epidemiology and pathogenesis of both community and healthcare-associated infections. Coinciding the emergence of methicillin-resistant (MRSA) is a challenge for clinicians to prevent their spread. Mupirocin is a topical antimicrobial agent approved for eradicating nasal carriage of staphylococcal species in adult patients and healthcare workers (HCWs).

View Article and Find Full Text PDF

Background: Skin and Soft Tissue Infections (SSTIs) Surveillance Network of In Pediatrics in China was established in 2009 to routinely report epidemiological changes. We aimed to monitor the present antibiotic sensitivity and molecular characteristics of and methicillin-resistant (MRSA) from SSTIs in children nationwide and track the changes over the past decade.

Methods: Patients diagnosed with SSTIs from the dermatology departments of 22 tertiary pediatric hospitals in seven geographical regions of China were recruited continuously from May 2019 to August 2021.

View Article and Find Full Text PDF

Mupirocin susceptibility of staphylococci 2022: Is it time for a change in MRSA decolonization protocols?

Am J Infect Control

July 2023

Departments of Microbiology and Infectious Diseases, Stamford Health, Stamford, CT; Division of Infectious Diseases, Columbia University Vagelos College of Physicians and Surgeons, New York, NY. Electronic address:

Background: Nasal decolonization with mupirocin has been a common strategy for the prevention of surgical site infections (SSIs) and recurrent skin and soft tissue infections due to Staphylococcus aureus (SA). We recently noted an increase in SSIs due to SA, including a case of post-operative mupirocin-resistant methicillin-resistant SA (MRSA) infection despite attempted preoperative decolonization with mupirocin. We therefore evaluated the mupirocin susceptibility of SA at our hospital to determine the optimal regimen for decolonization.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!